基于CAR的细胞疗法治疗头癌:对临床适用性的全面审查
Francesco Perri1, Margaret Ottaviano2, Miriam Tomaciello3
1Clinical and Experimental Head and Neck Medical Oncology Unit, INT IRCCS Foundation G Pascale, 80131 Naples, Italy.
化学抗原受体T细胞 (CAR-T) 疗法对头癌 (HNC) 有前途. 尽管在免疫抑制瘤微环境中存在挑战,但CAR-T细胞疗法可能为HNC管理提供未来的临床应用.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法是一种新型免疫疗法.
- 卡特-T疗法在血液性恶性瘤中有效,但在固体瘤中有限.
- 头癌 (HNC) 提出了独特的诊断和治疗挑战.
研究的目的:
- 探索在HNC中开发采用细胞疗法的理由.
- 为HNC的诊断和治疗挑战提供见解.
- 审查CAR-T细胞治疗在HNC管理中的应用.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 在PubMed数据库中搜索相关研究.
- 在HNC中专注于CAR-T细胞疗法.
主要成果:
- 瘤微环境 (TME) 构成了CAR-T细胞透的障碍.
- HNC TME具有免疫抑制作用,具有调节性T细胞 (Tregs) 和自然杀手 (NK) 细胞.
- 免疫细胞上CD16受体的低表达限制了抗体依赖细胞细胞毒性 (ADCC).
结论:
- 在HNC中,CAR-T疗法具有潜在的临床适用性.
- 克服TME挑战对于HNC的CAR-T疗效至关重要.
- 对于CAR-T在HNC中的应用,需要进一步的研究.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
